The Mt. Sinai study could open the door to future therapies for Alzheimer’s, amyotrophic lateral sclerosis, brain cancer, and ...
Learn more here. Moderna is a biotechnology company primarily engaged in the development and manufacturing of messenger RNA ...
This study is the first to demonstrate that certain tRNA introns influence gene expression. Scientists have discovered that ...
Jax Bari, an 11-year-old from Philadelphia, shows me a photo of himself. It's hard to look at; in it, he's sprawled out on ...
Scientists have developed a lipid nanoparticle system that enables mRNA to cross the blood-brain barrier, a long-standing challenge in n.
Scientists at the Icahn School of Medicine at Mount Sinai have developed a lipid nanoparticle system capable of delivering ...
Cells in the body have to move around in order to do their jobs. During development, for instance, cells are distributed to ...
A new discovery offers hope for Huntington’s disease. This discovery provides hope that a DNA repair process may help slow or ...
Analysis by Mount Sinai researcher from First-of-its kind global trial could lead to future therapies to prevent deadly ...
A phase 2 trial shows that olpasiran, an RNA-based therapy, reduces lipoprotein(a) [Lp(a)] levels by more than 95% in ...
Scientists have discovered that some tiny segments of RNA thought to be junk instead have a functional role in suppressing production of certain messenger RNAs and appear to help cells respond to ...
Scientists have developed a lipid nanoparticle system capable of delivering messenger RNA (mRNA) to the brain via intravenous injection, a challenge that has long been limited by the protective nature ...